Nardi Norma, Brito-Zerón Pilar, Ramos-Casals Manuel, Aguiló Sira, Cervera Ricard, Ingelmo Miguel, Font Josep
Department of Autoimmune Diseases, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), School of Medicine, University of Barcelona, C/Villaroel 170, 08036 Barcelona, Spain.
Clin Rheumatol. 2006 May;25(3):341-6. doi: 10.1007/s10067-005-0059-3. Epub 2005 Oct 25.
The aim of this study was to analyze the prevalence and clinical significance of circulating auto-antibodies against nuclear and non-nuclear antigens in a large cohort of Spanish patients with primary Sjögren's syndrome (SS). We studied 335 patients diagnosed with primary SS seen consecutively in our department since 1994 and tested for anti-nuclear antibodies (ANA), anti-Ro/SS-A, anti-La/SS-B, anti-Sm, anti-ribonucleoprotein (anti-RNP), anti-smooth muscle antibodies (anti-SMA), anti-parietal cell antibodies (anti-PCA), anti-liver-kidney microsome type-1 (anti-LKM-1) antibodies and anti-mitochondrial antibodies (AMA). ANA were detected in 278 (83%) patients. The association of positive ANA with the presence of anti-Ro/SS-A and anti-La/SS-B antibodies reached statistical significance at a titre of ANA >1/80 (p<0.001), while the presence of anti-Sm and anti-RNP was associated with positive ANA at a titre > or =1/320 (p=0.037 for Sm and p=0.016 for RNP). ANA titres correlated with the number of positive antibodies against specific nuclear antigens (p<0.001) but not with the number of positive antibodies against non-nuclear antigens. We found positive anti-Ro/SS-A antibodies in 111 (33%) patients, anti-La/SS-B in 78 (23%), anti-RNP in 8 (2%) and anti-Sm in 4 (1%). Anti-SMA antibodies were detected in 208 (62%) patients, with no significant associations with clinical or analytical SS features, while anti-PCA antibodies were found in 90 (27%) patients and were associated with a higher prevalence of thyroiditis and liver involvement. AMA were detected in 28 (8%) patients, although only 14 presented clinical and/or analytical evidence of liver involvement. No patient presented anti-LKM antibodies. ANA play a central role in the immunological expression of primary SS, due to their frequency and close association with the underlying presence of one or more anti-ENA antibodies. Positivity for antibodies against non-nuclear antigens such as anti-PCA and AMA suggests an association with some organ-specific autoimmune diseases (thyroiditis and primary biliary cirrhosis), while the presence of anti-SMA, in spite of their high prevalence, has no clinical significance in primary SS.
本研究旨在分析一大群西班牙原发性干燥综合征(SS)患者中循环抗核及非核抗原自身抗体的患病率及其临床意义。我们研究了自1994年起在我科连续就诊的335例诊断为原发性SS的患者,并检测了抗核抗体(ANA)、抗Ro/SS-A、抗La/SS-B、抗Sm、抗核糖核蛋白(抗RNP)、抗平滑肌抗体(抗SMA)、抗壁细胞抗体(抗PCA)、抗肝肾微粒体1型(抗LKM-1)抗体和抗线粒体抗体(AMA)。278例(83%)患者检测到ANA。ANA阳性与抗Ro/SS-A和抗La/SS-B抗体的存在之间的关联在ANA滴度>1/80时具有统计学意义(p<0.001),而抗Sm和抗RNP的存在与ANA滴度>或 =1/320时的ANA阳性相关(Sm为p=0.037,RNP为p= <0.001)。ANA滴度与针对特定核抗原的阳性抗体数量相关(p<0.001),但与针对非核抗原的阳性抗体数量无关。我们发现111例(33%)患者抗Ro/SS-A抗体阳性,78例(23%)抗La/SS-B抗体阳性,8例(2%)抗RNP抗体阳性,4例(1%)抗Sm抗体阳性。208例(62%)患者检测到抗SMA抗体,与临床或分析性SS特征无显著关联,而90例(27%)患者发现抗PCA抗体,且与甲状腺炎和肝脏受累的较高患病率相关。28例(8%)患者检测到AMA,尽管只有14例有肝脏受累的临床和/或分析证据。未发现患者有抗LKM抗体。ANA在原发性SS的免疫表达中起核心作用,这是由于其频率以及与一种或多种抗ENA抗体潜在存在的密切关联。针对非核抗原的抗体如抗PCA和AMA阳性提示与某些器官特异性自身免疫性疾病(甲状腺炎和原发性胆汁性肝硬化)有关,而抗SMA的存在尽管患病率高,但在原发性SS中无临床意义。